(Q33958890)

30 July 2017

1 reference

title

Role of activation of the coagulation factor VIII in interaction with vWf, phospholipid, and functioning within the factor Xase complex (English)

1 reference

30 July 2017

Saenko EL

1

1 reference

30 July 2017

Shima M

series ordinal

2

1 reference

30 July 2017

Sarafanov AG

series ordinal

3

1 reference

30 July 2017

publication date

1 October 1999

1 reference

Trends in Cardiovascular Medicine

30 July 2017

published in

1 reference

30 July 2017

volume

9

1 reference

30 July 2017

issue

7

1 reference

30 July 2017

page(s)

185-192

1 reference

Molecular basis of factor VIII inhibition by human antibodies. Antibodies that bind to the factor VIII light chain prevent the interaction of factor VIII with phospholipid

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2800%2900019-0

7 January 2021

The activation of human blood coagulation factor X on the surface of endothelial cells: a comparison with various vascular cells, platelets and monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2800%2900019-0

7 January 2021

The role of cleavage of the light chain at positions Arg1689 or Arg1721 in subunit interaction and activation of human blood coagulation factor VIII

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2800%2900019-0

7 January 2021

The size of human factor VIII heterodimers and the effects produced by thrombin

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2800%2900019-0

7 January 2021

Model for the factor VIIIa-dependent decay of the intrinsic factor Xase. Role of subunit dissociation and factor IXa-catalyzed proteolysis

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2800%2900019-0

7 January 2021

The A2 subunit of factor VIIIa modulates the active site of factor IXa.

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2800%2900019-0

7 January 2021

Activation of the factor VIIIa-factor IXa enzyme complex of blood coagulation by membranes containing phosphatidyl-L-serine

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2800%2900019-0

7 January 2021

Membrane-binding peptide from the C2 domain of factor VIII forms an amphipathic structure as determined by NMR spectroscopy

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2800%2900019-0

7 January 2021

Differential proteolytic activation of factor VIII-von Willebrand factor complex by thrombin

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2800%2900019-0

7 January 2021

Factor Va-membrane interaction is mediated by two regions located on the light chain of the cofactor

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2800%2900019-0

7 January 2021

Abnormal factor VIII Hiroshima: defect in crucial proteolytic cleavage by thrombin at Arg1689 detected by a novel ELISA.

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2800%2900019-0

7 January 2021

The effect of von Willebrand factor on activation of factor VIII by factor Xa

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2800%2900019-0

7 January 2021

Localization of a factor X interactive site in the A1 subunit of factor VIIIa

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2800%2900019-0

7 January 2021

The sequence Glu1811-Lys1818 of human blood coagulation factor VIII comprises a binding site for activated factor IX.

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2800%2900019-0

7 January 2021

Activation of porcine factor VIII:C by thrombin and factor Xa.

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2800%2900019-0

7 January 2021

The role of electrostatic interactions in the assembly of the factor X activating complex on both activated platelets and negatively-charged phospholipid vesicles.

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2800%2900019-0

7 January 2021

Interaction of factor IXa with factor VIIIa. Effects of protease domain Ca2+ binding site, proteolysis in the autolysis loop, phospholipid, and factor X

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2800%2900019-0

7 January 2021

Functional assembly of intrinsic coagulation proteases on monocytes and platelets. Comparison between cofactor activities induced by thrombin and factor Xa

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2800%2900019-0

7 January 2021

Role of factor VIII C2 domain in factor VIII binding to factor Xa

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2800%2900019-0

7 January 2021

Characterization of a genetically engineered inactivation-resistant coagulation factor VIIIa

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2800%2900019-0

7 January 2021

Proteolytic requirements for thrombin activation of anti-hemophilic factor (factor VIII)

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2800%2900019-0

7 January 2021

Cleavage of factor VIII light chain is required for maximal generation of factor VIIIa activity

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2800%2900019-0

7 January 2021

Activated protein C-catalyzed proteolysis of factor VIIIa alters its interactions within factor Xase

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2800%2900019-0

7 January 2021

A mechanism for inhibition of factor VIII binding to phospholipid by von Willebrand factor

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2800%2900019-0

7 January 2021

The acidic region of the factor VIII light chain and the C2 domain together form the high affinity binding site for von willebrand factor

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2800%2900019-0

7 January 2021

Activation of factor VIII by thrombin increases its affinity for binding to synthetic phospholipid membranes and activated platelets

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2800%2900019-0

7 January 2021

Slowed release of thrombin-cleaved factor VIII from von Willebrand factor by a monoclonal and a human antibody is a novel mechanism for factor VIII inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2800%2900019-0

7 January 2021

Binding of blood coagulation factor VIII and its light chain to phosphatidylserine/phosphatidylcholine bilayers as measured by ellipsometry.

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2800%2900019-0

7 January 2021

Structure of human factor VIII

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2800%2900019-0

7 January 2021

Distribution of factor VIII mRNA and antigen in human liver and other tissues

1 reference

https://api.crossref.org/works/10.1016%2FS1050-1738%2800%2900019-0

7 January 2021

10.1016/S1050-1738(00)00019-0

Identifiers

DOI

1 reference

30 July 2017

1 reference